Andrew Atkinson

Dr. Andrew Atkinson

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Pharmacology & Therapeutics
Verified
Journal Article
Closed access
HDHalina Dobrzynski
Halina Dobrzynski
RARobert H. Anderson
Robert H. Anderson
AAAndrew Atkinson
Andrew Atkinson
ZBZoltan Borbas
Zoltan Borbas
ADAlicia D'SOuza
Alicia D'SOuza
MBMark R. Boyett
Mark R. Boyett

3 August 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
RSRobert Stephenson
Robert Stephenson
AAAndrew Atkinson
Andrew Atkinson
PKPetros Kottas
Petros Kottas
FPFilip Perde
Filip Perde
FJFatemeh Jafarzadeh
Fatemeh Jafarzadeh
HDHalina Dobrzynski
Halina Dobrzynski
Cardiac arrhythmias and conduction disturbances are accompanied by structural remodelling of the specialised cardiomyocytes known collectively as the cardiac conduction system. Here, using contrast enhanced micro-computed tomography, we present, in attitudinally appropriate fashion, the first 3-dimensional representations of the cardiac conduction system within the intact human heart. We show that cardiomyocyte orientation can be extracted from these datasets at spatial resolutions approaching the single cell. These data show that commonly accepted anatomical representations are oversimplified. We have incorporated the high-resolution anatomical data into mathematical simulations of cardiac electrical depolarisation. The data presented should have multidisciplinary impact. Since the rate of depolarisation is dictated by cardiac microstructure, and the precise orientation of the cardiomyocytes, our data should improve the fidelity of mathematical models. By showing the precise 3-dimensional relationships between the cardiac conduction system and surrounding structures, we provide new insights relevant to valvar replacement surgery and ablation therapies. We also offer a practical method for investigation of remodelling in disease, and thus, virtual pathology and archiving. Such data presented as 3D images or 3D printed models, will inform discussions between medical teams and their patients, and aid the education of medical and surgical trainees.

15 April 2015 in Diabetes Care
Verified
Journal Article
Open access
PDF file
SAShazli Azmi
Shazli Azmi
MFMaryam Ferdousi
Maryam Ferdousi
IPIoannis N. Petropoulos
Ioannis N. Petropoulos
GPGeorgios Ponirakis
Georgios Ponirakis
UAUazman Alam
Uazman Alam
RMRAYAZ MALIK
RAYAZ MALIK
OBJECTIVE: Impaired glucose tolerance (IGT) through to type 2 diabetes is thought to confer a continuum of risk for neuropathy. Identification of subjects at high risk of developing type 2 diabetes and, hence, worsening neuropathy would allow identification and risk stratification for more aggressive management. RESEARCH DESIGN AND METHODS: Thirty subjects with IGT and 17 age-matched control subjects underwent an oral glucose tolerance test, assessment of neuropathic symptoms and deficits, quantitative sensory testing, neurophysiology, skin biopsy, and corneal confocal microscopy (CCM) to quantify corneal nerve fiber density (CNFD), branch density (CNBD), and fiber length (CNFL) at baseline and annually for 3 years. RESULTS: Ten subjects who developed type 2 diabetes had a significantly lower CNFD (P = 0.003), CNBD (P = 0.04), and CNFL (P = 0.04) compared with control subjects at baseline and a further reduction in CNFL (P = 0.006), intraepidermal nerve fiber density (IENFD) (P = 0.02), and mean dendritic length (MDL) (P = 0.02) over 3 years. Fifteen subjects who remained IGT and 5 subjects who returned to normal glucose tolerance had no significant baseline abnormality on CCM or IENFD but had a lower MDL (P < 0.0001) compared with control subjects. The IGT subjects showed a significant decrease in IENFD (P = 0.02) but no change in MDL or CCM over 3 years. Those who returned to NGT showed an increase in CNFD (P = 0.05), CNBD (P = 0.04), and CNFL (P = 0.05), but a decrease in IENFD (P = 0.02), over 3 years. CONCLUSIONS: CCM and skin biopsy detect a small-fiber neuropathy in subjects with IGT who develop type 2 diabetes and also show a dynamic worsening or improvement in corneal and intraepidermal nerve morphology in relation to change in glucose tolerance status.

7 June 2019 in Diabetologia
Verified
Journal Article
Open access
PDF file
SAShazli Azmi
Shazli Azmi
MJMaria Jeziorska
Maria Jeziorska
MFMaryam Ferdousi
Maryam Ferdousi
IPIoannis N. Petropoulos
Ioannis N. Petropoulos
GPGeorgios Ponirakis
Georgios Ponirakis
RMRAYAZ MALIK
RAYAZ MALIK
Aims/hypothesis The study aimed to assess the impact on neuropathy of simultaneous pancreas and kidney transplantation (SPK) in individuals with type 1 diabetes. Methods This longitudinal observational study examined neuropathic symptoms, deficits, quantitative sensory testing, neurophysiology, corneal confocal microscopy and skin biopsy results in 32 healthy (non-diabetic) control participants, 29 individuals with type 1 diabetes and severe diabetic peripheral neuropathy [DPN] and 36 individuals with type 1 diabetes after SPK. Results Following SPK, HbA1c, eGFR, triacylglycerols and HDL improved significantly (all p < 0.05). Compared with the DPN group, which remained unchanged over the 36 month study period, corneal confocal microscopy assessments improved over 36 months following SPK, with increasing corneal nerve fibre density of 5/mm2 (95% CI 1.8, 8.2; p = 0.003) and corneal nerve fibre length of 3.2 mm/mm2 (95% CI 0.9, 5.5; p = 0.006). The Neuropathy Symptom Profile and peroneal nerve conduction velocity also improved significantly by 36 months compared with DPN (2.5; 95% CI 0.7, 4.3; p = 0.008 and 4.7 m/s; 95% CI 2.2, 7.4; p = 0.0004, respectively), but with a temporal delay compared with the corneal confocal microscopy assessments. Intraepidermal nerve fibre density did not change following SPK; however, mean dendritic length improved significantly at 12 (p = 0.020) and 36 (p = 0.019) months. In contrast, there were no changes in the Neuropathy Disability Score, quantitative sensory testing or cardiac autonomic function assessments. Except for a small decrease in corneal nerve fibre density in the healthy control group, there were no changes in any other neuropathy measure in the healthy control or DPN groups over 36 months. Conclusions/interpretation SPK is associated with early and maintained small nerve fibre regeneration in the cornea and skin, followed by an improvement in neuropathic symptoms and peroneal nerve conduction velocity.

28 April 2011 in The Anatomical Record
Verified
Journal Article
Closed access
PDF file
NCNatalie Chandler
Natalie Chandler
OAOleg Aslanidi
Oleg Aslanidi
DBDavid Buckley
David Buckley
SIShin Inada
Shin Inada
SBSteven Birchall
Steven Birchall
HDHalina Dobrzynski
Halina Dobrzynski

1 November 2011 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
AAAndrew Atkinson
Andrew Atkinson
SIShin Inada
Shin Inada
JLJue Li
Jue Li
JTJames O. Tellez
James O. Tellez
JYJoseph Yanni
Joseph Yanni
HDHalina Dobrzynski
Halina Dobrzynski